169 related articles for article (PubMed ID: 35533965)
1. Co-delivery of Docetaxel and Resveratrol by liposomes synergistically boosts antitumor efficiency against prostate cancer.
Zhang L; Lin Z; Chen Y; Gao D; Wang P; Lin Y; Wang Y; Wang F; Han Y; Yuan H
Eur J Pharm Sci; 2022 Jul; 174():106199. PubMed ID: 35533965
[TBL] [Abstract][Full Text] [Related]
2. Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma.
Jhaveri A; Deshpande P; Pattni B; Torchilin V
J Control Release; 2018 May; 277():89-101. PubMed ID: 29522834
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin enhances the susceptibility of both androgen-dependent and -independent prostate carcinoma cells to docetaxel.
Liu QJ; Xu XH; Shang DH; Tian Y; Lü WC; Zhang YH
Chin Med J (Engl); 2010 Feb; 123(3):356-60. PubMed ID: 20193259
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacy.
Li J; Guo C; Feng F; Fan A; Dai Y; Li N; Zhao D; Chen X; Lu Y
Sci Rep; 2016 Dec; 6():38787. PubMed ID: 27934917
[TBL] [Abstract][Full Text] [Related]
5. Anti-breast cancer activity of resveratrol encapsulated in liposomes.
Zhao YN; Cao YN; Sun J; Liang Z; Wu Q; Cui SH; Zhi DF; Guo ST; Zhen YH; Zhang SB
J Mater Chem B; 2020 Jan; 8(1):27-37. PubMed ID: 31746932
[TBL] [Abstract][Full Text] [Related]
6. Ovarian tumor targeting of docetaxel-loaded liposomes mediated by luteinizing hormone-releasing hormone analogues. In vive distribution in nude mice.
Qin Y; Song QG; Zhang ZR; Liu J; Fu Y; He Q; Liu J
Arzneimittelforschung; 2008; 58(10):529-34. PubMed ID: 19025064
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy.
Zhang B; Wang T; Yang S; Xiao Y; Song Y; Zhang N; Garg S
J Control Release; 2016 Sep; 238():10-21. PubMed ID: 27432750
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and Efficacy of Low Temperature-Sensitive Liposome Encapsulated Docetaxel Combined with Mild Hyperthermia in a Mouse Model of Prostate Cancer.
Ranjan A; Benjamin CJ; Negussie AH; Chokshi S; Chung PH; Volkin D; Yeram N; Linehan WM; Dreher MR; Pinto PA; Wood BJ
Pharm Res; 2016 Oct; 33(10):2459-69. PubMed ID: 27343000
[TBL] [Abstract][Full Text] [Related]
9. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
[TBL] [Abstract][Full Text] [Related]
10. Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.
Eloy JO; Petrilli R; Topan JF; Antonio HMR; Barcellos JPA; Chesca DL; Serafini LN; Tiezzi DG; Lee RJ; Marchetti JM
Colloids Surf B Biointerfaces; 2016 May; 141():74-82. PubMed ID: 26836480
[TBL] [Abstract][Full Text] [Related]
11. EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells.
Eloy JO; Ruiz A; de Lima FT; Petrilli R; Raspantini G; Nogueira KAB; Santos E; de Oliveira CS; Borges JC; Marchetti JM; Al-Jamal WT; Chorilli M
Colloids Surf B Biointerfaces; 2020 Oct; 194():111185. PubMed ID: 32574928
[TBL] [Abstract][Full Text] [Related]
12. Caffeic acid phenethyl ester synergistically enhances docetaxel and paclitaxel cytotoxicity in prostate cancer cells.
Tolba MF; Esmat A; Al-Abd AM; Azab SS; Khalifa AE; Mosli HA; Abdel-Rahman SZ; Abdel-Naim AB
IUBMB Life; 2013 Aug; 65(8):716-29. PubMed ID: 23847086
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel in combination with metformin enhances antitumour efficacy in metastatic breast carcinoma models: a promising cancer targeting based on PEGylated liposomes.
Vakili-Ghartavol R; Mehrabian A; Mirzavi F; Rezayat SM; Mashreghi M; Farhoudi L; Kharrazi S; Sadri K; Jaafari MR
J Pharm Pharmacol; 2022 Sep; 74(9):1307-1319. PubMed ID: 35833585
[TBL] [Abstract][Full Text] [Related]
14. Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo.
Meng J; Guo F; Xu H; Liang W; Wang C; Yang XD
Sci Rep; 2016 Mar; 6():22390. PubMed ID: 26947928
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel-loaded RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes: Drug release, cytotoxicity, and antitumor efficacy.
Yoon HY; Kwak SS; Jang MH; Kang MH; Sung SW; Kim CH; Kim SR; Yeom DW; Kang MJ; Choi YW
Int J Pharm; 2017 May; 523(1):229-237. PubMed ID: 28341149
[TBL] [Abstract][Full Text] [Related]
16. A novel lipid-based nanomicelle of docetaxel: evaluation of antitumor activity and biodistribution.
Ma M; Hao Y; Liu N; Yin Z; Wang L; Liang X; Zhang X
Int J Nanomedicine; 2012; 7():3389-98. PubMed ID: 22848167
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional gold nanorods and docetaxel-encapsulated liposomes for combined thermo- and chemotherapy.
Hua H; Zhang N; Liu D; Song L; Liu T; Li S; Zhao Y
Int J Nanomedicine; 2017; 12():7869-7884. PubMed ID: 29123399
[TBL] [Abstract][Full Text] [Related]
18. Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer.
Patel K; Doddapaneni R; Sekar V; Chowdhury N; Singh M
Mol Pharm; 2016 Jun; 13(6):2049-58. PubMed ID: 27070720
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic/Pharmacodynamic Modeling of Schedule-Dependent Interaction between Docetaxel and Cabozantinib in Human Prostate Cancer Xenograft Models.
Chen W; Chen R; Li J; Fu Y; Yang L; Su H; Yao Y; Li L; Zhou T; Lu W
J Pharmacol Exp Ther; 2018 Jan; 364(1):13-25. PubMed ID: 29084815
[TBL] [Abstract][Full Text] [Related]
20. Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy.
Yang Y; Lu X; Liu Q; Dai Y; Zhu X; Wen Y; Xu J; Lu Y; Zhao D; Chen X; Li N
Eur J Pharm Sci; 2017 Jul; 105():219-229. PubMed ID: 28526602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
